Evidence-Based Gastroenterology and Hepatology

by McDonald, John W. D.; Burroughs, Andrew K.; Feagan, Brian G.; Fennerty, M. Brian

• ISBN13: 9781405181938
• ISBN10: 1405181931
• Edition: 3rd
• Format: Hardcover
• Copyright: 2010-09-20
• Publisher: B M J Books

Summary

This major textbook critically appraises the evidence for diagnosis, screening, and treatment of gastrointestinal and hepatic diseases, and provides clear recommendations for management. A unique feature is the grading of both the evidence (randomized controlled trials, systematic reviews, or lower quality trials) and the treatment recommendations. This structure provides the reader with valuable guidance on implementation.

Author Biography

John McDonald, Professor of Gastroenterology at the University of Ontario, London Ontario, Coordinating Editor in the Cochrane Collaboration Steering Committee on methodology, and Past President of the Canadian College of Gastroenterology

Professor Andrew Burroughs MBChB Hons FRCP
Consultant Physician and Hepatologist, Royal Free Hospital, London, has an international reputation as a clinical and academic Hepatologist and has published widely in all areas of liver disease. He is a full time clinician and has been awarded a personal chair, as Professor of Hepatology in the University of London.

Brian Feagan is Professor of Medicine and Epidemiology and Biostatistics at the University of Western Ontario. He holds cross-appointments in the Divisions of Internal Medicine, Clinical Pharmacology and Gastroenterology. He is a specialist in Internal Medicine with training in Clinical Epidemiology and Gastroenterology who has been the lead investigator in the design and implementation of randomized controlled trials since 1986. In addition to being an internationally recognized expert in the therapy of Inflammatory Bowel Disease, Dr. Feagan has conducted trials on behalf of Industry and peer-reviewed agencies in a wide range of disease states. Dr. Feagan is interested in the evaluation of Health Related Quality of Life (HRQL) and has performed research on the operating properties of HRQL instruments.

Table of Contents

Gastroesophageal reflux disease

Barett's esophagus

Esophageal motility disorders: achalasia and spastic motor disorders

Esinophilic esophagitis

Ulcer disease and helicobacter pylori

Non-steroidal anti-inflammatory drug-induced gastroduodenal and enteric toxicity

Non-variceal gastrointestinal hemorrhage

Functional dyspepsia

Celiac disease

Crohn's disease

Ulcerative colitis

Pouchitis after restorative proctocolectomy

Microscopic colitis: collagenous and lymphocytic colitis

Drug induced Diarreha

Metabolic bone disease in gastrointestinal disorders

Colorectal cancer in ulcerative colitis: surveillance

Colorectal cancer: population screening and surveillance

Prevention and treatment of travellers diarrhoea

Clostridium difficile disease

Irritable bowel syndrome

Ogilvie's syndrome

Gallstone disease

Acute pancreatitis

Obesity

Liver disease

Hepatitis C

Hepatitis B

Alcoholic liver disease

Non-alcoholic fatty liver disease

Hemochromatosis

Wilson disease

Primary biliary cirrhosis

Autoimmune hepatitis

Primary sclerosing cholangitis

Non histological assessment of hepatic fibrosis

Portal hypertensive bleeding

Hepatic outflow syndromes and splanchnic venous thrombosis

Ascites, hepatorenal syndrome and spontaneous bacterial peritonitis

Hepatic encephalopathy

Hepatocellular carcinoma

Acute liver failure

Liver transplantation: prevention and treatment of rejection

Liver transplantation: prevention and treatment of infection

Management of HCV infection and liver transplantation

Management of HBV infection and liver transplantation

Liver biopsy

Drug induced liver disease - mechanisms and diagnosis

Index

Table of Contents provided by Publisher. All Rights Reserved.